Editorial Article
Germany Quadrupled Its Cannabis Imports and Then Legislated the Channel That Sold Them
<h2>Two numbers in the same press release move in opposite directions</h2>
<p>On 8 October 2025 the German federal cabinet approved a draft law amending the Medizinal-Cannabisgesetz. The health ministry’s own press release makes the case for it with a pair of figures that do not describe the same market.</p>
<p>Imports of cannabis flowers for medical purposes rose from around 19 tonnes in the first half of 2024 to around 80 tonnes in the first half of 2025. Statutory health insurance (GKV) prescriptions, in the ministry’s own wording, rose only in the single-digit percentage range.</p>
<p>Those two facts cannot both be about patients. If the reimbursed prescription count barely moved while import volume went up several-fold, then the marginal tonne is not being bought by the insurance system. It is being bought by someone paying out of pocket, and it is reaching them through a channel the ministry has now decided is the problem.</p>
<h2>The arithmetic in the impact assessment does not close</h2>
<p>The ministry states that imports rose “by more than 400 percent” — von rund 19 auf rund 80 Tonnen. From 19 to 80 is +321.05%. To reach +400% from a base of 19 tonnes you would need 95 tonnes; from a base of 16 tonnes, 80 tonnes would be exactly +400%. So either the base was rounded down substantially (about 16, not 19), or the growth rate was rounded up substantially. Both numbers are described as “rund”, which is doing a lot of work.</p>
<p>I raise it because this is not a trade article, it is a legislative impact assessment. The headline that justifies restricting a distribution channel overstates the growth it is responding to by roughly eighty percentage points against its own stated endpoints. It is the same class of error as a stated CAGR that does not compound from its stated endpoints — small in isolation, and corrosive when it is the number the policy is sized against.</p>
<h2>What the draft actually does</h2>
<p>The mechanisms are specific, and each one has a distinct commercial consequence.</p>
<p><strong>In-person contact becomes the gateway., particularly the mail-order exclusion, which is the provision with the most concentrated lobbying interest on both sides.</p>
<p><strong>Whether “one in-person consultation per four quarters” is enforced as a documentation requirement or as a clinical one. Enforced as documentation, it is an administrative cost on telemedicine platforms. Enforced as a clinical standard with a physical examination, it is a capacity constraint on the physician workforce.</p>
<p><strong>Whether the import series turns. BfArM publishes the quarterly import quantities by weight, which is the cleanest public series in the sector and the only one that will show, without spin, whether the legislation changed what crosses the border.</p>
<h2>The point</h2>
<p>Europe’s medical cannabis market was not built by a clinical breakthrough. It was built by three administrative decisions — who may prescribe, from where, and how the product reaches the patient — and Germany has just moved two of them. The molecule did not change, the patients did not change and the evidence base did not change. The channel did, and in this category the channel is the market.</p>
Frequently Asked Questions
What changes under Germany's October 2025 medical cannabis amendment?
The cabinet-approved draft requires prescribing only after personal contact between patient and physician in the practice or on a home visit, with a history and usually a physical examination; continuing counselling on dependence risk; one in-person consultation per four quarters for repeat prescriptions, with telemedicine allowed for the following three; and it excludes mail-order delivery of medical cannabis.
How much medical cannabis does Germany import?
Around 80 tonnes of cannabis flowers in the first half of 2025, against around 19 tonnes in the first half of 2024, according to the Federal Ministry of Health's own statement accompanying the draft law.
Is the ministry's "more than 400 percent" growth figure correct?
It does not close against its own endpoints. From 19 tonnes to 80 tonnes is +321.05%. To reach +400% from a base of 19 tonnes you would need 95 tonnes; from a base of 16 tonnes, 80 tonnes would be exactly +400%. Both figures are given as approximate, which is where the gap comes from.
Can medical cannabis still be prescribed by telemedicine in Germany?
Under the draft, only after an in-person consultation within the preceding four quarters, and that contact must relate to the prescribing of medical cannabis. The following three quarters can then be handled remotely. Mail-order dispatch is excluded because the counselling obligations are held to require a personal consultation in the pharmacy.